Project Alleviation of proteasomal inhibition as a therapeutic approach for SCA3

Basic data

Title:

Alleviation of proteasomal inhibition as a therapeutic approach for SCA3

Duration:

01/01/2017 to 31/12/2017

Abstract / short description:

The project deals with the analysis of protein degradation mechanisms and their therapeutic potential for a neurodegenerative disorder (Spinocerebellar Ataxia Type 3).

Keywords:

neurodegenerative disorder

neurodegenerative Erkrankung

proteins

Proteine

therapies

Therapien

Involved staff

Managers

Schmidt, Jana

Faculty of Medicine
University of Tübingen

Local organizational units

Institute of Medical Genetics and Applied Genomics

Department of Diagnostic Laboratory Medicine
Hospitals and clinical institutes, Faculty of Medicine

Funders

National Ataxia Foundation

Minneapolis, Minnesota, United States of America